Pulmonary fibrosis is a rare, chronic disease that causes scarring in the lungs, making breathing difficult for people who suffer with it. And, as University of South Florida pulmonologist Dr. Jose ...

The CIC biomaGUNE Center for Cooperative Research in Biomaterials has developed pulmonary surfactant nanoparticles (the blend ...

University of South Florida pulmonologist Dr. Jose Herazo-Maya has focused his career on researching treatments for pulmonary fibrosis, a devastating and deadly lung disease. Pulmonary fibrosis in ...

But when Herazo-Maya, director of the Ubben Center for Pulmonary Fibrosis Research and an associate professor at the USF Health Morsani College of Medicine, began studying patients who developed ...

Researchers have uncovered changes in the cellular response throughout lung damage caused by SARS-CoV-2—the virus behind COVID-19. The team revealed distinct phases where waves of immune responses ...

Pulmonary fibrosis has emerged as a significant long-term complication of severe COVID-19, characterised by irreversible distortion of lung architecture and persistent impairment of gas exchange.

The study of long COVID remains in its infancy, with no FDA-approved treatment available, but the pandemic may be spawning new research into other medical areas, says the head of Northwestern's long ...

FREDERICKSBURG, Va. – Bailey Anne Vincent dances with all of her senses but one. She says she’s profoundly deaf from all usable hearing. "I am a choreographer, a professional dancer, a homeschooling ...